Award recordCONTRACT

CSL BEHRING L.L.C.

PIID VA24716F0601· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6505 · DRUGS AND BIOLOGICALS· FY2016· $358,782 net obligations· UEI H3WKVE9VBLY3· PA

Description

OBLIGATION OF FUNDS FOR VENDOR FINAL INVOICE: PHARMACY CONTROLLED SUBSTANCE

Base award description: PHARMACY CONTROLLED SUBSTANCE

First action · last action
2016-02-01 · 2019-08-21
Transactions
5
First transaction's obligation
$478,141
Base + all options value (sum of deltas)
$358,782
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 5 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$485,707$0Base award · 2016-02-01 · this action $478,141 · running total $478,141Modification P00002 · 2017-01-10 · this action $7,566 · running total $485,707Modification P00003 · 2017-08-29 · this action -$119,571 · running total $366,136Modification P00004 · 2017-12-14 · this action $32,857 · running total $398,993Modification P00005 · 2019-08-21 · this action -$40,211 · running total $358,782
  • Base2016-02-01+$478,141= $478,141
  • Mod P000022017-01-10+$7,566= $485,707
  • Mod P000032017-08-29-$119,571= $366,136
  • Mod P000042017-12-14+$32,857= $398,993
  • Mod P000052019-08-21-$40,211= $358,782
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-02-01+$478,141$478,141PHARMACY CONTROLLED SUBSTANCE
Mod P00002· OTHER ADMINISTRATIVE ACTION2017-01-10+$7,566$485,707PHARMACY CONTROLLED SUBSTANCE
Mod P00003· CHANGE ORDER2017-08-29−$119,571$366,136DE-OBLIGATION OF REMAINING FUNDS FOR: PHARMACY CONTROLLED SUBSTANCE
Mod P00004· OTHER ADMINISTRATIVE ACTION2017-12-14+$32,857$398,993OBLIGATION OF FUNDS FOR VENDOR FINAL INVOICE: PHARMACY CONTROLLED SUBSTANCE
Mod P00005· CHANGE ORDER2019-08-21−$40,211$358,782OBLIGATION OF FUNDS FOR VENDOR FINAL INVOICE: PHARMACY CONTROLLED SUBSTANCE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0690SINA DRUG LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$188,463FY2026
36C24726N0211BOSTON SCIENTIFIC CORP247-NETWORK CONTRACT OFFICE 7 (36C247)$248,982FY2026
36C24726F0100AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$228,396FY2026
36C24726F0053EXELAN PHARMACEUTICALS INC247-NETWORK CONTRACT OFFICE 7 (36C247)$4,765,853FY2026
36C24726F0043AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$109,456FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24716F0601_3600_V797D50358_3600 · retrieved 2026-09-26.